Amrutanjan Health Care Limited
NSE: AMRUTANJAN BSE: AMRUTANJAN
NSE
726.10
-3.75 (-0.51%)
Prev Close
729.85
Open Price
723
Volume
13,300
Today Low / High
720.5 / 745.2
52 WK Low / High
544.1 / 842.9
Range
690 - 762
BSE
728.85
-1.05 (-0.14%)
Prev Close
729.9
Open Price
725.55
Volume
1,048
Today Low / High
720.5 / 759
52 WK Low / High
548.05 / 829
Range
692 - 765
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 726.1 (target range: 690 - 762), reflecting a change of -3.75 (-0.5138%). On the BSE, it is listed at 728.85 (target range: 692 - 765), showing a change of -1.05 (-0.14386%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
31 Oct
723.00
0.15%
30 Oct
741.50
-1.57%
29 Oct
747.10
-0.75%
28 Oct
717.00
3.39%
27 Oct
715.30
0.67%
24 Oct
712.00
0.73%
23 Oct
716.30
-0.15%
21 Oct
725.00
-1.20%
20 Oct
712.20
0.50%
17 Oct
698.00
3.33%
16 Oct
704.90
-0.82%
15 Oct
704.90
-0.46%
14 Oct
704.35
0.43%
13 Oct
702.00
0.33%
10 Oct
703.10
0.23%
09 Oct
705.00
0.26%
08 Oct
709.90
0.11%
07 Oct
708.50
0.16%
06 Oct
726.70
-1.52%
03 Oct
714.50
0.93%
Amrutanjan Health Care Limited Graph
Amrutanjan Health Care Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Amrutanjan Health Care Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 726.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 728.85 | 736.14 | 662.52 - 809.75 |
| 743.43 | 594.74 - 892.11 | ||
| 750.72 | 525.50 - 975.93 | ||
| Bearish Scenario | 728.85 | 721.56 | 649.41 - 793.72 |
| 714.27 | 571.42 - 857.13 | ||
| 706.98 | 494.89 - 919.08 |
Overview of Amrutanjan Health Care Limited
ISIN
INE098F01031
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
21,628
Market Cap
20,969,127,904
Last Dividend
4.6
Official Website
IPO Date
2009-11-05
DCF Diff
-418.45
DCF
1,158
Financial Ratios Every Investor Needs
Stock Dividend of AMRUTANJAN
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-16 | September 16, 25 | 2.6 | 2.6 | 2025-09-16 | 2025-10-23 | |
| 2025-02-18 | February 18, 25 | 1 | 1 | 2025-02-18 | 2025-03-14 | |
| 2024-11-22 | November 22, 24 | 1 | 1 | 2024-11-22 | 2024-12-12 | |
| 2024-09-13 | September 13, 24 | 2.6 | 2.6 | 2024-09-16 | 2024-10-23 | |
| 2024-02-20 | February 20, 24 | 1 | 1 | 2024-02-20 | 2024-03-10 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 450.51 Cr | 223.21 Cr | 246.29 Cr | 0.5467 | 0.00 Cr | 59.10 Cr | 54.59 Cr | 50.83 Cr | 17.58 | 75.88 Cr | 0.1128 |
| 2024-03-31 | 421.23 Cr | 275.61 Cr | 145.62 Cr | 0.3457 | 0.00 Cr | 5.20 Cr | 48.72 Cr | 44.97 Cr | 15.50 | 68.16 Cr | 0.1068 |
| 2023-03-31 | 379.54 Cr | 181.98 Cr | 197.56 Cr | 0.5205 | 1.20 Cr | 4.46 Cr | 41.85 Cr | 39.83 Cr | 13.65 | 59.08 Cr | 0.1050 |
| 2022-03-31 | 405.45 Cr | 180.46 Cr | 224.98 Cr | 0.5549 | 1.13 Cr | 2.73 Cr | 79.84 Cr | 67.19 Cr | 23.00 | 94.70 Cr | 0.1657 |
| 2021-03-31 | 331.55 Cr | 140.19 Cr | 191.36 Cr | 0.5772 | 0.87 Cr | 2.44 Cr | 71.79 Cr | 61.19 Cr | 20.94 | 86.17 Cr | 0.1846 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 83.16 Cr | 421.39 Cr | 94.77 Cr | 326.6146 Cr | 2.08 Cr | -81.08 Cr | 27.26 Cr | 63.93 Cr | 1.23 Cr | 0.00 Cr | 41.70 Cr | 84.5832 Cr |
| 2024-03-31 | 25.76 Cr | 366.87 Cr | 78.38 Cr | 288.4883 Cr | 1.73 Cr | -24.04 Cr | 28.90 Cr | 49.54 Cr | 1.06 Cr | 0.00 Cr | 11.78 Cr | 69.9185 Cr |
| 2023-03-31 | 4.90 Cr | 362.09 Cr | 71.32 Cr | 290.7719 Cr | 0.91 Cr | -3.99 Cr | 28.83 Cr | 47.55 Cr | 7.22 Cr | -1.77 Cr | 0.06 Cr | 63.0121 Cr |
| 2022-03-31 | 83.48 Cr | 349.87 Cr | 84.74 Cr | 265.1238 Cr | 0.88 Cr | -82.60 Cr | 26.00 Cr | 43.47 Cr | 9.95 Cr | -1.70 Cr | 5.44 Cr | 77.4730 Cr |
| 2021-03-31 | 130.70 Cr | 274.27 Cr | 58.71 Cr | 215.5647 Cr | 1.34 Cr | -129.36 Cr | 17.46 Cr | 23.32 Cr | 0.00 Cr | -1.80 Cr | -24.48 Cr | 52.1034 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 50.8992 Cr | -30.9664 Cr | -13.4896 Cr | 15.3463 Cr | 6.4432 Cr | 10.1552 Cr | -35.5529 Cr | 50.8347 Cr | -0.4609 Cr | -13.2665 Cr | 1.6449 Cr |
| 2024-03-31 | 27.9106 Cr | 19.1650 Cr | -48.2664 Cr | 21.1929 Cr | -1.1908 Cr | 3.7120 Cr | -6.7177 Cr | 44.9726 Cr | -0.5572 Cr | -13.3863 Cr | -0.0796 Cr |
| 2023-03-31 | 19.2181 Cr | -2.4750 Cr | -14.0265 Cr | 10.2914 Cr | 2.7166 Cr | 4.9028 Cr | -8.9267 Cr | 53.6454 Cr | -0.5803 Cr | -14.4091 Cr | -2.8244 Cr |
| 2022-03-31 | 52.1956 Cr | -36.2119 Cr | -16.7024 Cr | 28.7322 Cr | -0.7189 Cr | 2.1862 Cr | -23.4634 Cr | 90.5766 Cr | -0.6920 Cr | -12.4765 Cr | -8.5421 Cr |
| 2021-03-31 | 89.7629 Cr | -87.7608 Cr | -6.2834 Cr | 87.8022 Cr | -4.3155 Cr | 2.9051 Cr | -1.9607 Cr | 81.9045 Cr | -0.6423 Cr | -4.6770 Cr | 6.2573 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 94.05 Cr | 49.39 Cr | 44.66 Cr | 0.4748 | 6.92 Cr | 8.31 Cr | 2.87 | 12.87 Cr | 0.0884 |
| 2025-03-31 | 135.56 Cr | 68.99 Cr | 71.24 Cr | 0.5255 | 18.99 Cr | 15.18 Cr | 5.25 | 22.53 Cr | 0.1120 |
| 2024-12-31 | 122.75 Cr | 55.80 Cr | 66.95 Cr | 0.5454 | 21.68 Cr | 19.25 Cr | 6.66 | 27.71 Cr | 0.1568 |
| 2024-09-30 | 109.92 Cr | 54.41 Cr | 55.51 Cr | 0.5050 | 11.95 Cr | 11.80 Cr | 4.08 | 17.65 Cr | 0.1073 |
| 2024-06-30 | 83.74 Cr | 59.45 Cr | 24.28 Cr | 0.2900 | 1.96 Cr | 4.62 Cr | 1.60 | 8.00 Cr | 0.0551 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 199.33 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -326.61 Cr |
| 2025-03-31 | 83.16 Cr | 185.12 Cr | 83.16 Cr | 55.82 Cr | 27.26 Cr | 290.67 Cr | 63.93 Cr | 421.39 Cr | 94.77 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 229.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -297.79 Cr |
| 2024-09-30 | 7.07 Cr | 222.30 Cr | 229.37 Cr | 34.63 Cr | 32.63 Cr | 305.60 Cr | 49.14 Cr | 382.60 Cr | 84.81 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 211.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -288.49 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 8.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 15.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 19.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 11.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 4.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2018-04-13 | April 13, 18 | 2:1 |
| 2012-10-25 | October 25, 12 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,691.00 | ₹4,057,269,307,777.00 | ₹1,560,957.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,750.00 | ₹1,791,918,531,000.00 | ₹507,648.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,547.20 | ₹1,200,532,104,000.00 | ₹354,108.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,198.00 | ₹997,172,161,850.00 | ₹4,250,063.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹976.20 | ₹982,281,297,448.00 | ₹458,973.00 |
| Mankind Pharma Limited | MANKIND | ₹2,374.00 | ₹979,888,655,260.00 | ₹593,376.00 |
| Lupin Limited | LUPIN | ₹1,970.00 | ₹899,813,260,000.00 | ₹1,017,448.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,144.00 | ₹664,437,056,712.00 | ₹3,557,381.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,490.50 | ₹656,471,632,500.00 | ₹178,331.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,891.90 | ₹533,895,710,547.00 | ₹398,056.00 |
| Laurus Labs Limited | LAURUSLABS | ₹955.00 | ₹515,532,778,545.00 | ₹1,545,380.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,270.00 | ₹322,204,356,860.00 | ₹106,475.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,470.00 | ₹308,590,991,280.00 | ₹102,972.00 |
| Cohance Lifesciences Limited | COHANCE | ₹750.65 | ₹287,174,023,641.00 | ₹1,868,848.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,678.30 | ₹262,815,467,914.00 | ₹161,945.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,320.20 | ₹250,263,511,009.00 | ₹201,169.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,504.00 | ₹237,600,000,000.00 | ₹20,034.00 |
| Eris Lifesciences Limited | ERIS | ₹1,595.00 | ₹217,260,618,630.00 | ₹40,743.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹16,552.00 | ₹212,360,322,728.00 | ₹44,605.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,279.00 | ₹207,818,060,479.00 | ₹289,175.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹898.50 | ₹176,611,966,914.00 | ₹69,248.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,090.00 | ₹172,820,354,560.00 | ₹544,131.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,029.00 | ₹154,227,731,184.00 | ₹43,861.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹820.00 | ₹146,870,093,400.00 | ₹412,471.00 |
| Granules India Limited | GRANULES | ₹565.80 | ₹137,301,959,513.00 | ₹384,403.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹906.60 | ₹111,222,910,097.00 | ₹27,716.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,152.00 | ₹102,119,398,064.00 | ₹17,413.00 |
| Strides Pharma Science Limited | STAR | ₹931.00 | ₹85,812,796,734.00 | ₹9,219,615.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹847.10 | ₹76,775,188,040.00 | ₹105,473.00 |
| FDC Limited | FDC | ₹463.40 | ₹75,446,192,926.00 | ₹252,545.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹459.90 | ₹70,411,636,474.00 | ₹53,434.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹351.50 | ₹68,747,008,324.00 | ₹149,622.00 |
| Sequent Scientific Limited | SEQUENT | ₹215.02 | ₹53,736,260,792.00 | ₹1,034,918.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹466.00 | ₹50,777,813,490.00 | ₹51,949.00 |
| Innova Captab Limited | INNOVACAP | ₹827.50 | ₹47,353,628,748.00 | ₹13,339.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹490.50 | ₹44,767,935,000.00 | ₹54,698.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹134.75 | ₹43,729,283,983.00 | ₹196,585.00 |
| Suven Life Sciences Limited | SUVEN | ₹197.50 | ₹43,063,037,658.00 | ₹121,485.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,393.00 | ₹39,577,862,895.00 | ₹6,288.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹725.00 | ₹36,771,351,125.00 | ₹86,075.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹472.95 | ₹33,298,399,463.00 | ₹3,329.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹326.00 | ₹32,692,096,956.00 | ₹54,666.00 |
Key Executives
Chief Sales Officer
R. Narayanan
Gender: Not Specified
Year Born:
Chief Financial Officer
Mr. N. Swaminathan
Gender: male
Year Born:
Executive Chairman & MD
Mr. Sambhu Prasad Sivalenka
Gender: male
Year Born: 1974
Chief Marketing Officer
Mani Bhagavatheeswaran
Gender: Not Specified
Year Born:
Chief Operating Officer of Supply Chain & Product Delivery
Mr. S. Jeyakanth
Gender: male
Year Born:
Compliance Officer & Company Secretary
Mr. Mahalingam Srinivasan
Gender: male
Year Born:
FAQs about Amrutanjan Health Care Limited
Who is the CEO of the company?
The CEO is Sambhu Prasad Sivalenka.
What is the current market price of the stock?
The current price is ₹724.10.
What is the 52-week price range?
The range is ₹544.1-842.9.
What is the market capitalization of the company?
The market capitalization is ₹2,096.91 crores.
What is the dividend yield?
The dividend yield is 0.64%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 38.45.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Amrutanjan Health Care Limited (ISIN: INE098F01031) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹2,096.91 crores and an average daily volume of 21,628 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹4.6.